EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study

Adeline Ngoh iD, Maria Clark iD, Rebecca Greenaway, Xiumin Chen iD, Kimberley M Reid iD, Katy Barwick iD, Esther Meyer, Dale Moulding iD, Natalie Trump, J Helen Cross iD, Sean D Fraser iD, Lachlan de Hayr iD und 4 weitere

Annals of Neurology · 2025

DOI: 10.1002/ana.27306 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Neurology, 2025. Verfasst von Adeline Ngoh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research into Rare Disease in Children, London, UK. Hauptthemen laut MEDLINE: Landau-Kleffner Syndrome, Receptors, N-Methyl-D-Aspartate. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Families of Landau Kleffner Syndrome, Guarantors of Brain, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Landau–Kleffner syndrome (LKS), is a rare, poorly‐understood epileptic encephalopathy with spike–wave activation in sleep associated with mutations in GRIN2A , encoding the N‐Methyl‐D‐Aspartate receptor (NMDAR) GluN2A subunit. Physicians rely on empirical treatments, with scarce information on treatment efficacy and outcomes. This study aims to improve the understanding and clinical management of LKS.

Methods

Fifty‐two patients with LKS were recruited via one quaternary referral center. Case‐notes review delineated clinical features, long‐term outcomes, and prognostic factors. Generalized estimating equations were used to determine the longitudinal association among electroencephalogram abnormalities, steroid therapy, and neuropsychological findings. After genetic screening, the impact of identified GRIN2A missense variants on NMDAR function was assessed using homology modeling, cell‐surface trafficking assays, and electrophysiology in artificial synapses. Whole exome/genome sequencing was performed on GRIN2A ‐negative patients to identify novel gene associations.

Results

LKS is complex with significant clinical and genetic heterogeneity. Besides speech and language impairment, many patients had other co‐morbidities and almost half have long‐term disability. Early age at disease onset was associated with worse outcomes. There was no reliable correlation between electroencephalogram findings and developmental scores. Steroid therapy improved language outcomes independently of electroencephalogram findings. GRIN2A mutations were identified in 15.5% of the cohort. Likely pathogenic variants in GABBR2 , SCN1A , TRPC1 , ERRFI1 , CTXN3 , IRX6 , and IQCA1 were identified in 7 GRIN2A‐ negative individuals.

Interpretation

For LKS, early intervention is important for long‐term outcomes. Furthermore, management should not be based solely on electroencephalogram findings. Genetic and functional investigations offer insights into disease pathophysiology and facilitate development of future targeted therapies. ANN NEUROL 2025;98:951–966

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Landau-Kleffner SyndromeReceptors, N-Methyl-D-AspartateHumansMaleFemaleCohort StudiesChildChild, PreschoolElectroencephalographyAdolescentAdultYoung AdultMutation

Substanzen

Receptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, Zayed Centre for Research into Rare Disease in Children, London, UK.
  • Paediatric Neurology, KK Women's and Children's Hospital, Singapore, Singapore.
  • Department of Neurology, Great Ormond Street Hospital, London, UK.
  • Department of Psychology, Great Ormond Street Hospital, London, UK.
  • Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
  • Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.

ORCID-Profile: Adeline Ngoh, Maria Clark, Xiumin Chen, Kimberley M Reid, Katy Barwick, Dale Moulding, J Helen Cross, Sean D Fraser, Lachlan de Hayr, Dimitri M Kullmann, Joseph W Lynch, Robert J Harvey, Manju A Kurian

Förderung

  • Families of Landau Kleffner Syndrome
  • Guarantors of Brain
  • National Institute for Health Research
  • National Health and Medical Research Council
  • Action Medical Research
  • Sir Jules Thorn Charitable Trust
  • Rosetrees Trust
  • Great Ormond Street Children's Charity

Zitieren

APA

Ngoh, A., Clark, M., Greenaway, R., Chen, X., Reid, K. M., Barwick, K., Meyer, E., Moulding, D., Trump, N., Cross, J. H., Fraser, S. D., de Hayr, L., Kullmann, D. M., Lynch, J. W., Harvey, R. J., & Kurian, M. A. (2025). Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study. Annals of Neurology. https://doi.org/10.1002/ana.27306

Vancouver

Ngoh A, Clark M, Greenaway R, Chen X, Reid KM, Barwick K, et al. Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study. Annals of Neurology. 2025. doi:10.1002/ana.27306

BibTeX
@article{Ngoh2025,
  author = {Ngoh, Adeline and Clark, Maria and Greenaway, Rebecca and Chen, Xiumin and Reid, Kimberley M and Barwick, Katy and Meyer, Esther and Moulding, Dale and Trump, Natalie and Cross, J Helen and Fraser, Sean D and de Hayr, Lachlan and Kullmann, Dimitri M and Lynch, Joseph W and Harvey, Robert J and Kurian, Manju A},
  title = {Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27306}
}
Kostenlos starten →